Literature DB >> 18201908

False positives in imaging genetics.

Andreas Meyer-Lindenberg1, Kristin K Nicodemus2, Michael F Egan2, Joseph H Callicott2, Venkata Mattay3, Daniel R Weinberger4.   

Abstract

Imaging genetics provides an enormous amount of functional-structural data on gene effects in living brain, but the sheer quantity of potential phenotypes raises concerns about false discovery. Here, we provide the first empirical results on false positive rates in imaging genetics. We analyzed 720 frequent coding SNPs without significant association with schizophrenia and a subset of 492 of these without association with cognitive function. Effects on brain structure (using voxel-based morphometry, VBM) and brain function, using two archival imaging tasks, the n-back working memory task and an emotional face matching task, were studied in whole brain and regions of interest and corrected for multiple comparisons using standard neuroimaging procedures. Since these variants are unlikely to impact relevant brain function, positives obtained provide an upper empirical estimate of the false positive association rate. In a separate analysis, we randomly permuted genotype labels across subjects, removing any true genotype-phenotype association in the data, to derive a lower empirical estimate. At a set correction level of 0.05, in each region of interest and data set used, the rate of positive findings was well below 5% (0.2-4.1%). There was no relationship between the region of interest and the false positive rate. Permutation results were in the same range as empirically derived rates. The observed low rates of positives provide empirical evidence that the type I error rate is well controlled by current commonly used correction procedures in imaging genetics, at least in the context of the imaging paradigms we have used. In fact, our observations indicate that these statistical thresholds are conservative.

Entities:  

Mesh:

Year:  2007        PMID: 18201908     DOI: 10.1016/j.neuroimage.2007.11.058

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  58 in total

1.  Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Authors:  Kristin K Nicodemus; Amanda J Law; Eugenia Radulescu; Augustin Luna; Bhaskar Kolachana; Radhakrishna Vakkalanka; Dan Rujescu; Ina Giegling; Richard E Straub; Kate McGee; Bert Gold; Michael Dean; Pierandrea Muglia; Joseph H Callicott; Hao-Yang Tan; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2010-10

2.  Brain vs behavior: an effect size comparison of neuroimaging and cognitive studies of genetic risk for schizophrenia.

Authors:  Emma Jane Rose; Gary Donohoe
Journal:  Schizophr Bull       Date:  2012-04-12       Impact factor: 9.306

3.  Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia.

Authors:  Aristotle N Voineskos; Daniel Felsky; Natasa Kovacevic; Arun K Tiwari; Clement Zai; M Mallar Chakravarty; Nancy J Lobaugh; Martha E Shenton; Tarek K Rajji; Dielle Miranda; Bruce G Pollock; Benoit H Mulsant; Anthony R McIntosh; James L Kennedy
Journal:  Cereb Cortex       Date:  2012-07-06       Impact factor: 5.357

4.  Development of PowerMap: a software package for statistical power calculation in neuroimaging studies.

Authors:  Karen E Joyce; Satoru Hayasaka
Journal:  Neuroinformatics       Date:  2012-10

5.  A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function.

Authors:  Heike Tost; Bhaskar Kolachana; Shabnam Hakimi; Herve Lemaitre; Beth A Verchinski; Venkata S Mattay; Daniel R Weinberger; Andreas Meyer-Lindenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-20       Impact factor: 11.205

Review 6.  Applying imaging genetics to ADHD: the promises and the challenges.

Authors:  Zhaomin Wu; Li Yang; Yufeng Wang
Journal:  Mol Neurobiol       Date:  2014-04-01       Impact factor: 5.590

7.  Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans.

Authors:  Alessandro Bertolino; Leonardo Fazio; Annabella Di Giorgio; Giuseppe Blasi; Raffaella Romano; Paolo Taurisano; Grazia Caforio; Lorenzo Sinibaldi; Gianluca Ursini; Teresa Popolizio; Emanuele Tirotta; Audrey Papp; Bruno Dallapiccola; Emiliana Borrelli; Wolfgang Sadee
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

8.  Neural connectivity as an intermediate phenotype: brain networks under genetic control.

Authors:  Andreas Meyer-Lindenberg
Journal:  Hum Brain Mapp       Date:  2009-07       Impact factor: 5.038

Review 9.  Abuse of amphetamines and structural abnormalities in the brain.

Authors:  Steven Berman; Joseph O'Neill; Scott Fears; George Bartzokis; Edythe D London
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Evidence of statistical epistasis between DISC1, CIT and NDEL1 impacting risk for schizophrenia: biological validation with functional neuroimaging.

Authors:  Kristin K Nicodemus; Joseph H Callicott; Rachel G Higier; Augustin Luna; Devon C Nixon; Barbara K Lipska; Radhakrishna Vakkalanka; Ina Giegling; Dan Rujescu; David St Clair; Pierandrea Muglia; Yin Yao Shugart; Daniel R Weinberger
Journal:  Hum Genet       Date:  2010-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.